Financial Performance - For the year ended December 31, 2022, the revenue from continuing operations was RMB 2,375.0 million, a decrease of 0.1% compared to RMB 2,377.2 million for the year ended December 31, 2021[8]. - The adjusted EBITDA for continuing operations was RMB 819.1 million, down 2.9% from RMB 843.2 million in the previous year[5]. - The gross profit for continuing operations was RMB 927.2 million, a decrease of 4.9% from RMB 975.2 million in 2021[8]. - The net profit attributable to the company's owners was RMB 290.8 million, compared to RMB 181.6 million in the previous year[8]. - The operating profit for the year was RMB 431.7 million, down from RMB 516.4 million in the previous year[24]. - The company reported a profit of RMB 267,187 thousand for the year, compared to RMB 126,105 thousand in the previous year, representing an increase of approximately 112%[26]. - Earnings per share (EPS) increased to RMB 0.18 from RMB 0.11, reflecting a growth of 63.64% year-over-year[26]. - The company reported a net profit from continuing operations of RMB 293,702 thousand for the year[42]. - The group reported a net profit attributable to owners of the company from continuing operations of RMB 233,124,000, down from RMB 298,349,000 in 2021[126]. - Net profit for 2022 was RMB 267.2 million, significantly up from RMB 126.1 million in 2021, primarily due to increased revenue from the health check-up segment and gains from the sale of a specialty hospital[151]. Revenue Breakdown - The revenue from outpatient services was RMB 88,122 thousand, down from RMB 90,805 thousand, a decrease of about 3.0%[98]. - The revenue from inpatient services was RMB 230,269 thousand, down from RMB 247,210 thousand, a decrease of approximately 6.9%[98]. - Revenue from health check services reached RMB 1,765,390,000, representing a growth of 4.1% from RMB 1,696,363,000 in 2021[113]. - Health check-up business revenue increased by 4.1% to RMB 1,765.4 million in 2022, driven by a 0.5% growth in the number of check-ups and a 3.5% increase in average spending per person[140]. - Revenue from comprehensive hospital services decreased by 10.4% to RMB 631,112,000 from RMB 704,209,000 in 2021, primarily due to an 11.1% decline in inpatient numbers[113]. Assets and Liabilities - Total assets as of December 31, 2022, amounted to RMB 4,566,858 thousand, a slight increase from RMB 4,536,199 thousand in 2021[28]. - The total liabilities amounted to RMB 3,662,032,000, while total equity was RMB 904,826,000[59]. - The current liabilities exceeded current assets by approximately RMB 797,540,000 as of December 31, 2022[49]. - The company’s total assets were RMB 4,566,858,000, with total liabilities and equity combined at the same amount[59]. - The asset-liability ratio improved to 63.6% as of December 31, 2022, down from 77.1% in 2021, due to a decrease in net financing and an increase in total equity[160]. Cash Flow and Financing - The company’s cash flow for operational needs is primarily supported by cash generated from operating activities and bank borrowings[49]. - The company has confidence in future operating cash flows and the ability to extend bank financing if necessary[49]. - The company plans to meet future cash flow needs through operating cash flow, borrowings from financial institutions, and issuing debt instruments or shareholder contributions[193]. - The company’s interest expenses for the year were RMB 123,052,000[59]. - The net financing cost for the continuing operations in 2022 was RMB 104.9 million, a decrease from RMB 125.1 million in 2021[172]. Operational Metrics - The total outpatient services provided by Nantong Ruici Hospital was 356,610, a slight decrease of 0.3% from 357,611 in 2021[4]. - The number of inpatient services provided decreased by 11.1% to 26,141 from 29,395 in the previous year[4]. - The company operates 74 health check centers nationwide, with 60 already in operation, covering 29 cities, primarily in first-tier, new first-tier, and second-tier cities[107]. - The group received a total of 3,258,924 customers for health check services in the reporting period, a slight increase of 0.5% compared to 3,243,761 in 2021[109]. - As of December 31, 2022, the nursing home had 101 residents with an occupancy rate of 94.2%, down from 95.3% in 2021, reflecting a decrease of 1.1 percentage points[107]. Strategic Initiatives - The company plans to continue its dual-brand strategy with "Ruici Health Check" and "Xingyuan International Health Check" to meet new consumer demands post-pandemic[2]. - The company aims to deepen its market presence in Shanghai and Jiangsu while actively developing the Greater Bay Area and Zhejiang markets[2]. - The company is focusing on expanding its market presence in the Greater Bay Area and other core cities while maintaining its dual-brand strategy in health check services[107]. - The company has signed cooperation agreements with six prestigious hospitals in Shanghai to develop specialized clinical medical centers, enhancing its service capabilities[106]. - The group is focusing on enhancing service quality and optimizing service processes in the health check segment, with significant improvements noted[135]. Cost and Expenses - Employee benefits expenses increased to RMB 901,209 thousand in 2022 from RMB 809,984 thousand in 2021, representing an increase of approximately 11.4%[99]. - The total operating expenses for the year ended December 31, 2022, amounted to RMB 1,953,633 thousand, up from RMB 1,875,127 thousand in 2021, reflecting a growth of about 4.2%[99]. - Sales costs rose by 3.3% from RMB 1,402.0 million in 2021 to RMB 1,447.8 million in 2022[142]. - The sales cost for the health check business in 2022 was RMB 977.0 million, an increase of 8.9% compared to RMB 897.2 million in 2021, primarily due to the expansion of the revenue scale[168]. Dividends and Shareholder Returns - The company did not declare or pay any dividends for the year ended December 31, 2022, consistent with 2021[102].
瑞慈医疗(01526) - 2022 - 年度业绩